Latest Industry Insights

Technology Networks connected with Dr. Kyle Luttgeharm, product manager at Agilent, head of his talk for the Technology Networks online symposium: Vaccine Research and Development 2022.

In this interview, we hear from Dr. Eliza Small about the current challenges facing RNA therapeutic development and how these challenges can be overcome.

Technology Networks sat down with 2022 Illumina Agricultural Greater Good Initiative Grant winner Dr. Ranjana Bhattacharjee to learn more about her plans to use genomic analysis to improve the productivity and sustainability of yam crops.

In this article, learn how semiconductor manufacturer STMicroelectronics is using advanced HPC technologies to help its customers and partners explore the world of next-generation wireless.

This article discusses an innovative biofabrication method that uses a single 3D hydrodynamic flow focusing chip to generate different hydrogel configurations with specific geometries for various biological applications.

Only 10 years ago, Nobel prize-winning work introduced CRISPR as a new and powerful genome editing tool. Here, three noteworthy applications of the technology are highlighted.

Technology Networks spoke to Conor McKechnie, to learn more about the Biopharma Resilience Index and the changes required to get new therapeutics to market quicker.

Technology Networks recently had the pleasure of speaking with Mark Fidock, vice president for Diagnostic Development, Precision Medicine at AstraZeneca, to find out how the company is “rising to the challenge” of delivering precision medicines for chronic diseases.

BYOD has become an essential cornerstone of modern clinical trials. This article discusses the adoption of BYOD and the benefits it can bring to patients.

In this article, Technology Networks speaks with Mindset Pharma CEO James Lanthier about how patents work in the fast-changing psychedelics industry, what makes a patent effective and how newer compounds stack up against natural psychedelics.